These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 5037291

  • 41. Letter: Amphotericin pharmacophobia and renal toxicity.
    Forgan-Smith R, Darrell JH.
    Br Med J; 1974 Feb 09; 1(5901):244. PubMed ID: 4818170
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Is liposomal amphotericin B really safety in neonates?
    Karadag-Oncel E, Ozsurekci Y, Yurdakok M, Kara A.
    Early Hum Dev; 2013 Jan 09; 89(1):35-6. PubMed ID: 22877627
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain.
    Aguado JM, Lumbreras C, González-Vidal D, Grupo de Farmacovigilancia de Abelcet.
    Clin Microbiol Infect; 2004 Sep 09; 10(9):785-90. PubMed ID: 15355408
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. [Chemotherapy of mycoses of the inner organs].
    Scholer HJ.
    Schweiz Med Wochenschr; 1968 Apr 20; 98(16):602-11. PubMed ID: 5688589
    [No Abstract] [Full Text] [Related]

  • 51. Treatment of blastomycosis and histoplasmosis in the dog.
    Ausherman RJ.
    J Am Vet Med Assoc; 1973 Nov 01; 163(9):1048-9. PubMed ID: 4747901
    [No Abstract] [Full Text] [Related]

  • 52. Treatment of fungal diseases. A statement by the committee on therapy.
    Am Rev Respir Dis; 1969 Dec 01; 100(6):908-10. PubMed ID: 5357705
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries.
    Ullmann AJ, Sanz MA, Tramarin A, Barnes RA, Wu W, Gerlach BA, Krobot KJ, Gerth WC, Longitudinal Evaluation of Antifungal Drugs (LEAD I) Investigators.
    Clin Infect Dis; 2006 Aug 15; 43(4):e29-38. PubMed ID: 16838223
    [Abstract] [Full Text] [Related]

  • 55. Implementation of clinical practice policy on the continuous intravenous administration of amphotericin B deoxycholate.
    Maharom P, Thamlikitkul V.
    J Med Assoc Thai; 2006 Nov 15; 89 Suppl 5():S118-24. PubMed ID: 17718252
    [Abstract] [Full Text] [Related]

  • 56. Reduced nephrotoxicity of conventional amphotericin B therapy after minimal nephroprotective measures: animal experiments and clinical study.
    Mayer J, Doubek M, Doubek J, Horký D, Scheer P, Stepánek M.
    J Infect Dis; 2002 Aug 01; 186(3):379-88. PubMed ID: 12134234
    [Abstract] [Full Text] [Related]

  • 57. Amphotericin-B nephrotoxicity in humans decreased by sodium supplements with coadministration of ticarcillin or intravenous saline.
    Branch RA, Jackson EK, Jacqz E, Stein R, Ray WA, Ohnhaus EE, Meusers P, Heidemann H.
    Klin Wochenschr; 1987 Jun 01; 65(11):500-6. PubMed ID: 3475498
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. [Systemic mycoses. 2. Systemic mycoses caused by dimorphous fungi (African histoplasmosis, blastomycosis, paracoccidioidomycosis,, sporotrichosis)].
    Meinhof W.
    Fortschr Med; 1976 Sep 16; 94(26):1392-4. PubMed ID: 976915
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.